Vericel (VCEL) Equity Average (2011 - 2026)
Vericel's (VCEL) quarterly Equity Average came in at $355.4 million in Q1 2026, up 21.01% year-on-year from $293.7 million in Q1 2025, and up 5.08% quarter-over-quarter from $338.2 million in Q4 2025.
Vericel (VCEL) Equity Average (2011 - 2026) Analysis & Trends
Vericel has disclosed Equity Average across 16 years of filings, most recently posting $355.4 million for Q1 2026.
- Equity Average for Q1 2026 came in at $355.4 million, up 21.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $355.4 million (up 21.01% YoY), and the FY2025 annual result was $323.3 million, up 24.85% from the prior year.
- Equity Average came in at $355.4 million for Q1 2026 at Vericel, up from $338.2 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $355.4 million in Q1 2026 to a low of $171.5 million in Q1 2022.
- The 5-year median for Equity Average is $229.9 million (2024), against an average of $241.7 million.
- Across the five-year window, Equity Average rose 12.63% in 2023 and gained 27.75% in 2025, its largest moves.
- Vericel's Equity Average stood at $185.1 million in 2022, then grew by 16.27% to $215.2 million in 2023, then grew by 27.68% to $274.7 million in 2024, then gained by 23.13% to $338.2 million in 2025, then grew by 5.08% to $355.4 million in 2026.
- The last three Equity Average figures came in at $355.4 million (Q1 2026), $338.2 million (Q4 2025), and $314.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 355.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355.44 Mn |
| Dec 31, 2025 | 338.25 Mn |
| Sep 30, 2025 | 314.33 Mn |
| Jun 30, 2025 | 301.15 Mn |
| Mar 31, 2025 | 293.73 Mn |
| Dec 31, 2024 | 274.72 Mn |
| Sep 30, 2024 | 250.22 Mn |
| Jun 30, 2024 | 238.44 Mn |
| Mar 31, 2024 | 229.92 Mn |
| Dec 31, 2023 | 215.17 Mn |
| Sep 30, 2023 | 201.65 Mn |
| Jun 30, 2023 | 196.45 Mn |
| Mar 31, 2023 | 193.13 Mn |
| Dec 31, 2022 | 185.05 Mn |
| Sep 30, 2022 | 176.33 Mn |
| Jun 30, 2022 | 173.65 Mn |
| Mar 31, 2022 | 171.47 Mn |
| Dec 31, 2021 | 163.62 Mn |
| Sep 30, 2021 | 153.94 Mn |
| Jun 30, 2021 | 145.65 Mn |